12
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Electrocardiogram-based Deep Learning and Clinical Risk Factors to Predict Atrial Fibrillation

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background: Artificial intelligence (AI)-enabled analysis of 12-lead electrocardiograms (ECGs) may facilitate efficient estimation of incident atrial fibrillation (AF) risk. However, it remains unclear whether AI provides meaningful and generalizable improvement in predictive accuracy beyond clinical risk factors for AF.

          Methods: We trained a convolutional neural network ("ECG-AI") to infer 5-year incident AF risk using 12-lead ECGs in patients receiving longitudinal primary care at Massachusetts General Hospital (MGH). We then fit three Cox proportional hazards models, each composed of: a) ECG-AI 5-year AF probability, b) the Cohorts for Heart and Aging in Genomic Epidemiology AF (CHARGE-AF) clinical risk score, and c) terms for both ECG-AI and CHARGE-AF ("CH-AI"). We assessed model performance by calculating discrimination (area under the receiver operating characteristic curve, AUROC) and calibration in an internal test set and two external test sets (Brigham and Women's Hospital and UK Biobank). Models were recalibrated to estimate 2-year AF risk in the UK Biobank given limited available follow-up. We used saliency mapping to identify ECG features most influential on ECG-AI risk predictions and assessed correlation between ECG-AI and CHARGE-AF linear predictors.

          Results: The training set comprised 45,770 individuals (age 55±17 years, 53% women, 2,171 AF events), and the test sets comprised 83,162 individuals (age 59±13 years, 56% women, 2,424 AF events). AUROC was comparable using CHARGE-AF (MGH 0.802, 95% CI 0.767-0.836; BWH 0.752, 95% CI 0.741-0.763; UK Biobank 0.732, 95% CI 0.704-0.759) and ECG-AI (MGH 0.823, 95% CI 0.790-0.856; BWH 0.747, 95% CI 0.736-0.759; UK Biobank 0.705, 95% CI 0.673-0.737). AUROC was highest using CH-AI: MGH 0.838, 95% CI 0.807-0.869; BWH 0.777, 95% CI 0.766-0.788; UK Biobank 0.746, 95% CI 0.716-0.776). Calibration error was low using ECG-AI (MGH 0.0212; BWH 0.0129; UK Biobank 0.0035) and CH-AI (MGH 0.012; BWH 0.0108; UK Biobank 0.0001). In saliency analyses, the ECG P-wave had the greatest influence on AI model predictions. ECG-AI and CHARGE-AF linear predictors were correlated (Pearson r MGH 0.61, BWH 0.66, UK Biobank 0.41).

          Conclusions: AI-based analysis of 12-lead ECGs has similar predictive utility to a clinical risk factor model for incident AF and both approaches are complementary. ECG-AI may enable efficient quantification of future AF risk.

          Related collections

          Author and article information

          Contributors
          (View ORCID Profile)
          (View ORCID Profile)
          (View ORCID Profile)
          (View ORCID Profile)
          (View ORCID Profile)
          (View ORCID Profile)
          (View ORCID Profile)
          (View ORCID Profile)
          (View ORCID Profile)
          Journal
          Circulation
          Circulation
          Ovid Technologies (Wolters Kluwer Health)
          0009-7322
          1524-4539
          November 08 2021
          Affiliations
          [1 ]Division of Cardiology, Massachusetts General Hospital, Boston, MA; Cardiovascular Research Center, Massachusetts General Hospital, Boston, MA; Cardiovascular Disease Initiative, Broad Institute of Harvard and the Massachusetts Institute of Technology, Cambridge, MA
          [2 ]Data Sciences Platform, Broad Institute of Harvard and the Massachusetts Institute of Technology, Cambridge, MA
          [3 ]Cardiovascular Research Center, Massachusetts General Hospital, Boston, MA; Cardiovascular Disease Initiative, Broad Institute of Harvard and the Massachusetts Institute of Technology, Cambridge, MA
          [4 ]Harvard Medical School, Boston, MA; Biostatistics Center, Massachusetts General Hospital, Boston, MA
          [5 ]Cardiovascular Research Center, Massachusetts General Hospital, Boston, MA; Cardiovascular Disease Initiative, Broad Institute of Harvard and the Massachusetts Institute of Technology, Cambridge, MA; Harvard Medical School, Boston, MA; Cardiac Arrhythmia Service, Massachusetts General Hospital, Boston, MA
          [6 ]Harvard Medical School, Boston, MA; Cardiac Arrhythmia Service, Massachusetts General Hospital, Boston, MA; Department of Neurology, Brigham and Women's Hospital, Boston, MA; Center for Genomic Medicine, Massachusetts General Hospital, Boston, MA; Henry and Allison McCance Center for Brain Health, Massachusetts General Hospital, Boston, MA
          [7 ]Division of Cardiology, Massachusetts General Hospital, Boston, MA; Cardiovascular Research Center, Massachusetts General Hospital, Boston, MA; Cardiovascular Disease Initiative, Broad Institute of Harvard and the Massachusetts Institute of Technology, Cambridge, MA; Harvard Medical School, Boston, MA
          [8 ]Data Sciences Platform, Broad Institute of Harvard and the Massachusetts Institute of Technology, Cambridge, MA; Eric and Wendy Schmidt Center, Broad Institute of Harvard and the Massachusetts Institute of Technology, Cambridge, MA
          Article
          10.1161/CIRCULATIONAHA.121.057480
          8748400
          34743566
          e0f968c4-c8a7-45ac-a355-82b49c019a79
          © 2021
          History

          Comments

          Comment on this article